The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis

Clinical Rheumatology

Volumn 16, Issue 2, 1997, Pages 167-172

  Hein, G ^a,b   Franke, S ^a   Muller A ^a   Braunig E ^a   Eidner, T ^a   Stein, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Rheumatology O ^*  (Germany)

Author keywords

Cartilage degradation; Collagen crosslinks; Pyridinium compounds; Rheumatoid arthritis

Indexed keywords

COLLAGEN; CORTICOSTEROID; DMARD; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CARTILAGE DEGENERATION; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; URINE LEVEL;

EID: 0030977223     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02247846     Document Type: Article

References (24)

1. Seibel M J, Zipf A, Ziegler R. Pyridinium-Crosslinks im Urin. Dtsch med Wschr 1994; 199: 923-9.
2. Campion GV, McCrea F, Schnitzer TJ, Lenz ME, Dieppe PA, Thonar EJMA. Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 1991; 34: 1254-9.
3. Kleesieck R, Reinards R, Okusi J, Wolf B, Greiling H. UDP-D-xylose: proteoglycan core protein β-D-xylosyltransferase: A new marker of cartilage destruction in chronic joint diseases. J Clin Chem Clin Biochem 1987; 25: 473-81.
4. Mollenhauer J, Müller N, Thonar EJ. Neue Ansätze zur Labor-diagnostik der Osteoarthrose. Orthopäde 1990; 19: 1-8.
5. Seibel MJ. Komponenten der extrazellulären Gewebematrix als potentielle "Marker" des Bindegewebs-, Knorpel- und Knochen-metabolismus bei Erkrankungen des Bewegungsapparates. Z Rheumatol 1989; 48: 6-18.
6. Fife RS, Rachow JW, Ryan LM. Synovial fluid and plasma levels of cartilage matrix glycoprotein in arthritis. Calcif Tissue Int 1994; 55: 100-102.
7. Mansson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, Heinegard D, Saxne T. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease indentified by serum markers of cartilage metabolism. J Clin Invest 1995; 3; 1071-7.
8. Poole AR, Dieppe P. Biological markers in rheumatoid arthritis. Semin Arthriti Rheum 1994; 23 (6); Suppl 2, 17-31.
9. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed phase high performance liquid chromatography. Anal Biochem 1988, 169, 197-203.
10. Seibel MJ, Robins SP, Bilezikian JP. Urinary pyridinium crosslinks of collagen specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992, 3, 263-70.
11. Chalkins E. Semi-quantitative criteria of estimating degrees of activity of rheumatoid arthritis. Committee Report to Am Rheum 1962, quot. by Lansbury In: Hollander JL, Mc Carthy D J Jr. (eds), Arthritis and Allied Conditions. Methods of evaluating rheumatoid arthritis. Lea and Febiger, Philadelphia, 1972, 419-38.
12. Larsen A, Dale K. Standardized radiological evaluation of rheumatoid arthritis in therapeutic trials. In: Dumande D C, Jasani J K (eds), Recognition of anti-rheumatic drugs. MTP Press, Lancester, 1978, 285-292.
13. Steinbrocker O, Traeger Ch, Baetterman R O. Therapeutic criteria for rheumatoid arthritis. JAMA 1949, 140, 659-62.
14. James I, Crowley C. Assay of pyridinium crosslinks in serum using narrow-bore ion-paired reversed-phase high performance liquid chromatography. J Chromatogr 1993, 612, 41-8.
15. Colwell A, Russel R G, Eastell R. Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 1993, 23, 341-9.
16. Astbury C, Bird H A, McLaren A M, Robins S P. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 1994, 33, 11-5.
17. Spector T D, James I T, Hall G M, Thompson P W, Perret D, Hart D J. Increased levels of urinary collagen crosslinks in females with rheumatoid arthritis. Clin Rheumatol 1993, 12, 240-4.
18. Robins S P, McLaren A M, Nicol P, Seibel M J. Pyridinium crosslink measurements in serum and synovial fluid of patients with osteoarthritis. In: Keuttner K E, Schleyerbach R, Peyron J G, Hascall V C (eds), Articular Cartilage and Osteoarthritis. Raven Press, New York, 1992, 738-9.
19. Abbiati G, Rigoldi M, Frignani S, Colombo L, Mussini E. Determination of pyridinium crosslinks in plasma and serum by high-performance liquid chromatography. J Chromatogr 1994, B 656, 303-10.
20. Abbiati G, Bartucci F, Longoni A, Fincato G, Galimberti S, Rigoldi M, Castiglioni C. Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: sample realationships between 24-h and fasting early morning urine concentrations. Bone and Mineral 1993, 21, 9-19.
21. Seibel M J, Duncan A, Robins S P, Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989, 16, 964-70.
22. Black D, Marabini M, Sturrock R D, Robins S P. Urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 1989, 48, 641-44/
23. Kollerup G, Hansen M, Hørslev-Petersen K. Urinary hydroxypyridinium crosslinks of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone. Br J Rheum 1994, 33, 816-20.
24. Müller A, Hein G, Franke S, Herrmann D, Henzgen S, Roth A, Stein G. Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high performance liquid chromatography. Rheumatol Int 1996, 16,23-8.